Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Neoplasms × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 52 Ovarian Neoplasms 4 Neoplasms 3 Inflammatory Breast Neoplasms 3 HER2-positive Breast Cancer 3 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 HER2-Positive Early Breast Cancer 1 HER2 Positive Breast Cancer 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 6 Radiotherapy 2 Pemetrexed 2 Carboplatin 2 Brachytherapy 2 tucatinib 1 seribantumab 1 osimertinib 1 gedatolisib 1 fosaprepitant 1 fluciclovine F-18 1 cobimetinib 1 atezolizumab 1 alovudine 1 Trastuzumab 1 Therapeutics 1 TP protocol 1 Saline Solution 1 Radiation 1 Protons 1 Palliative Care 1 Nivolumab 1 Letrozole 1 Immunoglobulin G 1 Imatinib Mesylate 1 Ifosfamide 1 Gemcitabine 1 Fulvestrant 1 FANG vaccine 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡